Wellington Management Group
GILD icon

Wellington Management Group’s Gilead Sciences GILD Stock Holding History

Wellington Management Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-350
Closed -$200K – 2214
2016
Q3 		$200K Buy
+350
New +$28.4K ﹤0.01% 2138

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group's GILD Position: Q1 2026 in Review

Wellington Management Group reduced its Gilead Sciences (GILD) stake by 15% in Q1 2026, selling an estimated $332M and leaving 13,537,991 shares worth $1.89B. The position accounts for 0.35% of the portfolio, ranked #62.

Wellington Management Group first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.16B in Q2 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Wellington Management Group held 13,537,991 shares of Gilead Sciences worth $1.89B as of Q1 2026.
  • Wellington Management Group sold 2,369,313 Gilead Sciences shares in Q1 2026, an estimated $332M.
  • Gilead Sciences made up 0.35% of Wellington Management Group's portfolio in Q1 2026, its #62 holding.
  • Wellington Management Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Wellington Management Group's Gilead Sciences position peaked at $4.16B in Q2 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.